Abbonarsi

Differences in disease presentation between men and women with sarcoidosis: A cohort study - 25/01/22

Doi : 10.1016/j.rmed.2021.106688 
Amanda Lundkvist a, Susanna Kullberg b, c, Elizabeth V. Arkema d, Kerstin Cedelund e, Anders Eklund c, Johan Grunewald b, c, Pernilla Darlington a, f,
a Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden 
b Department of Respiratory Medicine, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden 
c Respiratory Medicine Division, Department of Medicine, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden 
d Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden 
e Department of Clinical Science, Intervention and Technology, Division of Medical Imaging and Technology at Karolinska Institutet, Stockholm, Sweden 
f Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden 

Corresponding author. Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden.Department of Internal MedicineSödersjukhusetStockholmSweden

Abstract

Background

Sarcoidosis is an elusive disease due to its heterogeneity. It is well recognized that the clinical picture is dependent on ethnicity, organ involvement and age. However, data on the role of sex is inconsistent. We aimed to study the gender-related differences in disease presentation in Swedish patients with sarcoidosis.

Subjects and methods

Clinical data was collected between 1996 and 2020, yielding a register with 1429 cases with sarcoidosis in a pulmonary clinic. The diagnosis was met according to WASOG criteria. Data on age, radiologic stage at the time of disease onset, and potential extra-pulmonary manifestations, was retrieved. Differences between men and women were analyzed with Fisher's Exact Test and t-test where appropriate.

Results

In the register there were 61% men and they were approximately three years younger than the women at the time of diagnosis. Men presented with a more advanced radiographic stage on chest imaging compared to women, radiographic stage II (46% vs 36%, p < 0.001), while women compared to men more often had stage 0-I disease on pulmonary x-rays (6% vs 2%, p < 0.001 for stage 0 and 46% vs 38%, p < 0.01 for stage I). Women had more cutaneous involvement (13% vs 8%, p < 0.01) and more often involvement of salivary glands (3% vs 1%, p < 0.05).

Conclusions

In this cohort with sarcoidosis patients, there was a predominance of men. They presented with more severe disease at a younger age, while women more often were found to have involvement of the skin and salivary glands.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

Among sarcoidosis cases men were overrepresented and younger at disease onset.
Men more often had radiographic stage II while stage 0-I were more common in women.
Women more often had involvement of the skin and salivary glands.

Il testo completo di questo articolo è disponibile in PDF.

Riassunto

Keypoints: We aimed to study differences between men and women with sarcoidosis. We found that men were overrepresented, in general younger at disease onset and had a more advanced radiographic stage on chest imaging compared to women.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Gender differences, Prognosis, Sarcoidosis


Mappa


© 2021  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 191

Articolo 106688- gennaio 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Differential serum lipid distribution in IPAH and CHD-PAH patients
  • Jingyuan Chen, Anandharajan Rathinasabapathy, Jun Luo, Xiaojie Yang, Peng Luo, Yusi Chen, Zilu Li, Jiang Li
| Articolo seguente Articolo seguente
  • Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function
  • Pranai Tandon, Tayseer Mosleh, Ali Mustafa, Hope Miodownik, Marc Miller, Adam S. Morgenthau

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.